Clinical Trial Update: The Efficacy of Suvorexant in Treatment of Patients With Substance Use Disorder and Insomnia: A Pilot Open Trial [Phase 2, Phase 3]

View source ↗

Summary

Pilot open-label trial examining suvorexant for sleep disturbance and craving in substance use disorder shows completed study with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Substance Use Disorder

Drugs mentioned

• Suvorexant (suvorexant)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Sleep Disturbance, Craving | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-02-12